Respiratory infections
Thoracic oncology
PG5 Postgraduate course
Pleural disease: integrating 2021 evidence with real life cases
Clinical
Aims : To present all aspects of pleural disease, including 1) the pathophysiology of effusion formation and symptoms; 2) the optimal diagnostic methods, including emerging data on rationalisation steps and direct-to-biopsy strategies; 3) a synthesis of high-quality evidence that enables management of patients with malignant pleural effusion; 4) the evolving oncological management of mesothelioma; 5) pleural infection: from bench-to-bedside; and 6) a review of the optimal management of pneumothorax, including the results of soon to be published phase III trials of ambulatory/conservative strategies.
Target audience :
Clinical researcher, General practitioner, Thoracic oncologist, Thoracic surgeon
09:30
Mechanisms of effusion formation and symptoms – physiology, consequences and implications for management
S. Zarogiannis(Larisa, Greece)
COI
O. Kotsiou(Larissa, Greece)
COI
-
Description
1
09:50
Discussion and Q&A
S. Zarogiannis(Larisa, Greece)
COI
2
10:00
Interactive case
O. Kotsiou(Larissa, Greece)
COI
S. Zarogiannis(Larisa, Greece)
COI
3
10:45
Diagnostic pleural pathway: time for pathway rationalisation?
R. Banka(Mumbai (Maharashtra), India)
COI
D. Addala(Oxford, United Kingdom)
COI
-
Description
5
11:05
Discussion and Q&A
R. Banka(Mumbai (Maharashtra), India)
COI
6
11:15
Interactive case
R. Banka(Mumbai (Maharashtra), India)
COI
D. Addala(Oxford, United Kingdom)
COI
7
12:00
Malignant pleural effusion: drainage, talc and beyond
K. Blyth(Glasgow (Glasgow), United Kingdom)
COI
K. Ferguson(Glasgow, United Kingdom)
COI
-
Description
9
12:20
Discussion and Q&A
K. Blyth(Glasgow (Glasgow), United Kingdom)
COI
10
12:30
Interactive case
K. Ferguson(Glasgow, United Kingdom)
COI
K. Blyth(Glasgow (Glasgow), United Kingdom)
COI
11
14:00
Pleural infection: are we getting it right
N. Rahman(ABINGDON, United Kingdom)
COI
E. Bedawi(Sheffield, United Kingdom)
COI
-
Description
13
14:20
Discussion and Q&A
N. Rahman(ABINGDON, United Kingdom)
COI
14
14:30
Interactive case
E. Bedawi(Sheffield, United Kingdom)
COI
N. Rahman(ABINGDON, United Kingdom)
COI
15
15:15
Mesothelioma: emerging evidence and updated guidelines
A. Scherpereel(Lille Cedex, France)
COI
S. Tsim(Glasgow (Glasgow), United Kingdom)
COI
-
Description
17
15:35
Discussion and Q&A
A. Scherpereel(Lille Cedex, France)
COI
18
15:45
Interactive case
A. Scherpereel(Lille Cedex, France)
COI
S. Tsim(Glasgow (Glasgow), United Kingdom)
COI
19
16:30
Pneumothorax 2021: beyond the current guidelines
J. Janssen(Nijmegen, Netherlands)
COI
R. Mercer(Winchester, United Kingdom)
COI
-
Description
21
16:50
Discussion and Q&A
J. Janssen(Nijmegen, Netherlands)
COI
22
17:00
Interactive case
J. Janssen(Nijmegen, Netherlands)
COI
R. Mercer(Winchester, United Kingdom)
COI
23
. . .
